Provide the active pharmaceutical ingredient (API) concentration, dosage form (solution, suspension, or gel), specific packaging type (single-dose vs. multi-dose), target market regulatory standards, and annual volume forecast.
Category market report
Ophthalmic Drugs
Total suppliers
7,274+
Total Chinese suppliers export
$11.3B+
Recommended
High-quality suppliers related to Ophthalmic Drugs.
Suppliers
Find more suppliers who may be worth contacting.
Top suppliers
Suppliers in this category.
- Transactions
1,897
2018-012022-032026-08Transaction trend for Astrazeneca Pharmaceutical Co., Ltd.
- 2018-01: 4
- 2018-02: 2
- 2018-03: 3
- 2018-04: 4
- 2018-05: 3
- 2018-06: 10
- 2018-07: 5
- 2018-09: 10
- 2018-10: 2
- 2018-11: 1
- 2018-12: 1
- 2019-01: 32
- 2019-02: 19
- 2019-03: 17
- 2019-04: 13
- 2019-05: 19
- 2019-06: 16
- 2019-07: 9
- 2019-08: 5
- 2019-09: 4
- 2019-10: 7
- 2019-11: 13
- 2019-12: 15
- 2020-01: 24
- 2020-02: 1
- 2020-03: 18
- 2020-04: 30
- 2020-05: 27
- 2020-06: 14
- 2020-07: 13
- 2020-08: 38
- 2020-09: 4
- 2020-10: 21
- 2020-11: 28
- 2020-12: 16
- 2021-01: 9
- 2021-02: 42
- 2021-03: 23
- 2021-04: 20
- 2021-05: 44
- 2021-06: 23
- 2021-07: 19
- 2021-08: 33
- 2021-09: 15
- 2021-10: 46
- 2021-11: 27
- 2021-12: 22
- 2022-01: 43
- 2022-02: 9
- 2022-03: 22
- 2022-04: 30
- 2022-05: 24
- 2022-06: 26
- 2022-07: 19
- 2022-08: 18
- 2022-09: 19
- 2022-10: 34
- 2022-11: 12
- 2022-12: 37
- 2023-01: 13
- 2023-02: 19
- 2023-03: 51
- 2023-04: 22
- 2023-05: 12
- 2023-06: 26
- 2023-07: 23
- 2023-08: 17
- 2023-09: 45
- 2023-10: 10
- 2023-11: 32
- 2023-12: 15
- 2024-02: 28
- 2024-03: 12
- 2024-05: 31
- 2024-06: 18
- 2024-07: 16
- 2024-08: 6
- 2024-09: 15
- 2024-10: 16
- 2024-11: 11
- 2024-12: 14
- 2025-01: 21
- 2025-02: 14
- 2025-03: 19
- 2025-04: 13
- 2025-05: 9
- 2025-06: 11
- 2025-07: 20
- 2025-08: 17
- 2025-09: 13
- 2025-10: 7
- 2025-11: 13
- 2025-12: 16
- 2026-01: 21
- 2026-03: 13
- 2026-04: 49
- 2026-05: 34
- 2026-06: 28
- 2026-07: 28
- 2026-08: 14
- Amount
4,100,621.13
2018-012022-032026-08Amount trend for Astrazeneca Pharmaceutical Co., Ltd.
- 2018-01: 19.5M
- 2018-02: 23.3K
- 2018-03: 613.5K
- 2018-04: 401K
- 2018-05: 53.6K
- 2018-06: 195.8K
- 2018-07: 174.2K
- 2018-09: 1.4M
- 2018-10: 143.4K
- 2018-11: 27.6K
- 2018-12: 23K
- 2019-01: 40.7B
- 2019-02: 2.8M
- 2019-03: 2.4M
- 2019-04: 1.7M
- 2019-05: 2.6M
- 2019-06: 3.1M
- 2019-07: 1.8M
- 2019-08: 840.4K
- 2019-09: 772.1K
- 2019-10: 2.5M
- 2019-11: 2M
- 2019-12: 1.8M
- 2020-01: 7M
- 2020-02: 9,942.19
- 2020-03: 3.1M
- 2020-04: 4.1M
- 2020-05: 4.5M
- 2020-06: 5.9M
- 2020-07: 2.1M
- 2020-08: 7.6M
- 2020-09: 281.4K
- 2020-10: 1.8M
- 2020-11: 2.3M
- 2020-12: 2.1M
- 2021-01: 927.7K
- 2021-02: 5.9M
- 2021-03: 3M
- 2021-04: 2.8M
- 2021-05: 6.3M
- 2021-06: 4.1M
- 2021-07: 2.5M
- 2021-08: 4M
- 2021-09: 3.4M
- 2021-10: 7M
- 2021-11: 3.9M
- 2021-12: 4M
- 2022-01: 8.5M
- 2022-02: 2.3M
- 2022-03: 2.2M
- 2022-04: 5.2M
- 2022-05: 2.8M
- 2022-06: 4.1M
- 2022-07: 3.3M
- 2022-08: 2.1M
- 2022-09: 2.8M
- 2022-10: 5.3M
- 2022-11: 2M
- 2022-12: 5.9M
- 2023-01: 1.2M
- 2023-02: 3.3M
- 2023-03: 6.5M
- 2023-04: 3.4M
- 2023-05: 3.1M
- 2023-06: 3.4M
- 2023-07: 2.5M
- 2023-08: 2.8M
- 2023-09: 6.7M
- 2023-10: 1.9M
- 2023-11: 5.4M
- 2023-12: 3.1M
- 2024-02: 8.1M
- 2024-03: 3.1M
- 2024-05: 5.5M
- 2024-06: 3.3M
- 2024-07: 3M
- 2024-08: 1.3M
- 2024-09: 2.5M
- 2024-10: 2.2M
- 2024-11: 2M
- 2024-12: 1.8M
- 2025-01: 4.7M
- 2025-02: 1M
- 2025-03: 2.5M
- 2025-04: 2.9M
- 2025-05: 2.5M
- 2025-06: 1.9M
- 2025-07: 3M
- 2025-08: 1.3M
- 2025-09: 2.8M
- 2025-10: 661.9K
- 2025-11: 2M
- 2025-12: 3.1M
- 2026-01: 1.9M
- 2026-03: 697.5K
- 2026-04: 3.1M
- 2026-05: 1.7M
- 2026-06: 1.4M
- 2026-07: 799.3K
- 2026-08: 117.8K
- Main export countries
- India (0.6%)
- Sri Lanka (0%)
- Namibia (0%)
- Mexico (99.3%)
- Transactions
231
2018-012021-052025-08Transaction trend for Zoetis Suzhou Mfg Co., Ltd.
- 2018-01: 4
- 2018-02: 3
- 2018-03: 4
- 2018-04: 1
- 2018-05: 2
- 2018-06: 4
- 2018-07: 1
- 2018-09: 4
- 2018-11: 2
- 2018-12: 3
- 2019-01: 9
- 2019-02: 4
- 2019-03: 3
- 2019-04: 7
- 2019-05: 8
- 2019-06: 3
- 2019-07: 7
- 2019-08: 4
- 2019-09: 1
- 2019-10: 5
- 2019-11: 7
- 2020-01: 2
- 2020-03: 2
- 2020-04: 7
- 2020-05: 7
- 2020-06: 4
- 2020-09: 4
- 2020-11: 7
- 2021-03: 2
- 2021-04: 1
- 2021-05: 10
- 2021-06: 3
- 2021-07: 2
- 2021-09: 2
- 2021-10: 2
- 2021-11: 2
- 2022-04: 2
- 2022-05: 2
- 2022-07: 2
- 2022-10: 2
- 2022-11: 4
- 2022-12: 1
- 2023-03: 1
- 2023-04: 2
- 2023-06: 2
- 2023-09: 4
- 2024-01: 1
- 2024-04: 5
- 2024-05: 13
- 2024-06: 10
- 2024-07: 4
- 2024-08: 5
- 2024-09: 3
- 2024-10: 6
- 2024-11: 8
- 2024-12: 2
- 2025-01: 2
- 2025-02: 1
- 2025-03: 1
- 2025-04: 1
- 2025-05: 3
- 2025-08: 1
- Amount
564,082.25
2018-012021-052025-08Amount trend for Zoetis Suzhou Mfg Co., Ltd.
- 2018-01: 2.4M
- 2018-02: 788K
- 2018-03: 1.2M
- 2018-04: 3.2M
- 2018-05: 95.9K
- 2018-06: 941K
- 2018-07: 13.3M
- 2018-09: 1.3M
- 2018-11: 2M
- 2018-12: 1.8M
- 2019-01: 5.5B
- 2019-02: 273.6K
- 2019-03: 292.8K
- 2019-04: 648.4K
- 2019-05: 2.9M
- 2019-06: 2.1M
- 2019-07: 6.3M
- 2019-08: 3.3M
- 2019-09: 94.7K
- 2019-10: 465.6K
- 2019-11: 617.2K
- 2020-01: 108.3K
- 2020-03: 165.6K
- 2020-04: 437.4K
- 2020-05: 503.9K
- 2020-06: 169K
- 2020-09: 352K
- 2020-11: 629.8K
- 2021-03: 180.9K
- 2021-04: 27.6K
- 2021-05: 709.9K
- 2021-06: 431.7K
- 2021-07: 64K
- 2021-09: 28K
- 2021-10: 3.2M
- 2021-11: 4.3M
- 2022-04: 83.1K
- 2022-05: 72.9K
- 2022-07: 4.7M
- 2022-10: 2.3M
- 2022-11: 4.3M
- 2022-12: 30.7K
- 2023-03: 4.1M
- 2023-04: 80.3K
- 2023-06: 7.5M
- 2023-09: 240.3K
- 2024-01: 0
- 2024-04: 4.6M
- 2024-05: 112K
- 2024-06: 2.4M
- 2024-07: 242.3K
- 2024-08: 9.7M
- 2024-09: 268.5K
- 2024-10: 8.3M
- 2024-11: 13.4M
- 2024-12: 431.2K
- 2025-01: 124.8K
- 2025-02: 193.3K
- 2025-03: 193.9K
- 2025-04: 64.6K
- 2025-05: 10.9M
- 2025-08: 36.7K
- Main export countries
- Peru (0.5%)
- Indonesia (97.8%)
- United States (0.9%)
- Not available (0.9%)
- Transactions
47
2019-012020-102021-09Transaction trend for Puyang Hotway Pharmacy Co., Ltd.
- 2019-01: 32
- 2019-11: 2
- 2020-04: 2
- 2020-05: 1
- 2020-06: 1
- 2020-10: 1
- 2021-03: 2
- 2021-04: 1
- 2021-05: 1
- 2021-07: 1
- 2021-08: 1
- 2021-09: 2
- Amount
559,462.81
2019-012020-102021-09Amount trend for Puyang Hotway Pharmacy Co., Ltd.
- 2019-01: 5.6B
- 2019-11: 24.9K
- 2020-04: 22.1K
- 2020-05: 11.8K
- 2020-06: 12.3K
- 2020-10: 11.9K
- 2021-03: 24.6K
- 2021-04: 12.5K
- 2021-05: 12.7K
- 2021-07: 12.5K
- 2021-08: 12.5K
- 2021-09: 25.3K
- Main export countries
- Indonesia (100%)
Intelligence
China export momentum, destination markets, and regional demand.
China export trend
China export trend
- Date 2018-07: Value 3.5B USD
- Date 2018-08: Value 3.4B USD
- Date 2018-09: Value 3.1B USD
- Date 2018-10: Value 3.2B USD
- Date 2018-11: Value 3.8B USD
- Date 2018-12: Value 3.8B USD
- Date 2019-01: Value 3.7B USD
- Date 2019-02: Value 2.4B USD
- Date 2019-03: Value 3.7B USD
- Date 2019-04: Value 4B USD
- Date 2019-05: Value 4.4B USD
- Date 2019-06: Value 3.7B USD
- Date 2019-07: Value 4.1B USD
- Date 2019-08: Value 4B USD
- Date 2019-09: Value 3.9B USD
- Date 2019-10: Value 4.2B USD
- Date 2019-11: Value 4.6B USD
- Date 2019-12: Value 4.8B USD
- Date 2020-01: Value 0 USD
- Date 2020-02: Value 6.8B USD
- Date 2020-03: Value 5.1B USD
- Date 2020-04: Value 4.6B USD
- Date 2020-05: Value 3.9B USD
- Date 2020-06: Value 0 USD
- Date 2020-07: Value 0 USD
- Date 2020-08: Value 0 USD
- Date 2020-09: Value 4.3B USD
- Date 2020-10: Value 3.3B USD
- Date 2020-11: Value 3.8B USD
- Date 2020-12: Value 3.5B USD
- Date 2021-01: Value 224M USD
- Date 2021-02: Value 195M USD
- Date 2021-03: Value 237M USD
- Date 2021-04: Value 246M USD
- Date 2021-05: Value 225M USD
- Date 2021-06: Value 225M USD
- Date 2021-07: Value 252M USD
- Date 2021-08: Value 222M USD
- Date 2021-09: Value 260M USD
- Date 2021-10: Value 258M USD
- Date 2021-11: Value 263M USD
- Date 2021-12: Value 289M USD
- Date 2022-01: Value 285M USD
- Date 2022-02: Value 210M USD
- Date 2022-03: Value 303M USD
- Date 2022-04: Value 257M USD
- Date 2022-05: Value 279M USD
- Date 2022-06: Value 263M USD
- Date 2022-07: Value 277M USD
- Date 2022-08: Value 269M USD
- Date 2022-09: Value 261M USD
- Date 2022-10: Value 234M USD
- Date 2022-11: Value 281M USD
- Date 2022-12: Value 241M USD
- Date 2023-01: Value 230M USD
- Date 2023-02: Value 211M USD
- Date 2023-03: Value 264M USD
- Date 2023-04: Value 245M USD
- Date 2023-05: Value 282M USD
- Date 2023-06: Value 264M USD
- Date 2023-07: Value 225M USD
- Date 2023-08: Value 260M USD
- Date 2023-09: Value 269M USD
- Date 2023-10: Value 204M USD
- Date 2023-11: Value 249M USD
- Date 2023-12: Value 279M USD
- Date 2024-01: Value 377M USD
- Date 2024-02: Value 253M USD
- Date 2024-03: Value 348M USD
- Date 2024-04: Value 314M USD
- Date 2024-05: Value 263M USD
- Date 2024-06: Value 372M USD
- Date 2024-07: Value 335M USD
- Date 2024-08: Value 354M USD
- Date 2024-09: Value 326M USD
- Date 2024-10: Value 314M USD
- Date 2024-11: Value 356M USD
- Date 2024-12: Value 421M USD
- Date 2025-01: Value 394M USD
- Date 2025-02: Value 265M USD
- Date 2025-03: Value 367M USD
- Date 2025-04: Value 362M USD
- Date 2025-05: Value 356M USD
- Date 2025-06: Value 367M USD
- Date 2025-07: Value 387M USD
- Date 2025-08: Value 354M USD
- Date 2025-09: Value 370M USD
- Date 2025-10: Value 253M USD
- Date 2025-11: Value 394M USD
- Date 2025-12: Value 394M USD
- Date 2026-01: Value 421M USD
- Date 2026-02: Value 299M USD
- Date 2026-03: Value 352M USD
- Date 2026-04: Value 382M USD
- Date 2026-05: Value 350M USD
- Date 2026-06: Value 432M USD
- Date 2026-07: Value 400M USD
Top destinations
- Germany23B
- United States13.5B
- France9.5B
- Italy8.5B
- Sweden8B
- Australia6.7B
- United Kingdom5.9B
- Japan5.2B
- Switzerland3.5B
- Ireland2.9B
Top destinations
- Germany: 23,032,000,000 USD
- United States: 13,539,000,000 USD
- France: 9,534,000,000 USD
- Italy: 8,456,000,000 USD
- Sweden: 7,990,000,000 USD
- Australia: 6,680,000,000 USD
- United Kingdom: 5,913,000,000 USD
- Japan: 5,192,000,000 USD
- Switzerland: 3,452,000,000 USD
- Ireland: 2,890,000,000 USD
Key findings
Largest import market
23.03B USD
Germany · last 8 years
Fastest demand growth
84,913.74
Montenegro · last 8 years
Highest unit price
$2,523.67 /kg
Sweden · +21,722.17% vs avg
Turn this market into qualified conversations.
Your agent contacts, compares, and screens the suppliers that fit.
Insights
Product insights to guide your sourcing.
Product Trends
Preservative-free (PF) single-dose formulations and advanced multi-dose PF eye drops are seeing rapid demand growth. Fixed-combination generic therapies for glaucoma also show strong market potential in clinical sourcing.
Industrial Cluster Analysis
Primary clusters are in Shandong (leading in dry eye sodium hyaluronate drops) and Guangdong (Guangzhou Nansha), specializing in PIC/S and international GMP-compliant sterile lines suitable for large-scale CDMO exports.
Quality Expectations
Buyers require strict sterile manufacturing standards (SAL 10^-6). Key compliance metrics include tight particle size limits for ophthalmic suspensions and negligible leachables from packaging materials during long-term storage.
What You Need to Know
Request recent Batch Certificates of Analysis (COA), GMP compliance certificates (WHO/PIC/S), and stability test reports. Inspect sterile container-closure integrity and particle distribution reports from pilot batches.
MOQ for sterile lines is usually 50,000 to 100,000 units per run. Lead times range from 60 to 90 days, which includes the mandatory 14-day sterility incubation testing and batch release validation procedures before dispatch.
Budget for product registration and clinical trial verification fees in the importing country, temperature-controlled cold chain logistics, custom sterile packaging molds, and third-party pre-shipment sterility testing.
